These cumulative findings pivot the role of PD-1 in PJI into a new focal point, suggesting that its modulation could represent a novel therapeutic frontier for addressing the complex interplay of immune regulation and bone metabolism to improve local bone health and limit post-PJI prosthesis failure. Here, PDCD1 is linked to juvenile polyposis syndrome.